1206 related articles for article (PubMed ID: 14745517)
1. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
[TBL] [Abstract][Full Text] [Related]
2. Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study.
Maza S; Valencia R; Geworski L; Zander A; Guski H; Winzer KJ; Munz DL
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):651-6. PubMed ID: 12612811
[TBL] [Abstract][Full Text] [Related]
3. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
[TBL] [Abstract][Full Text] [Related]
4. [Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group].
Fortunato L; Drago S; Vitelli CE; Santoni M; Gucciardo G; Cabassi A; Farina M; La Pinta M; Remedi M; Pagano G; Silipod T; Terribile D; Stagnitto D; Grassi GB;
Chir Ital; 2006; 58(6):689-96. PubMed ID: 17190273
[TBL] [Abstract][Full Text] [Related]
5. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
6. Use of Tc99m-nanocolloid for sentinel nodes identification in cervical cancer.
Hubalewska A; Sowa-Staszczak A; Huszno B; Markocka A; Pityński K; Basta A; Opławski M; Basta P
Nucl Med Rev Cent East Eur; 2003; 6(2):127-30. PubMed ID: 14737727
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.
Babiera GV; Delpassand ES; Breslin TM; Ross MI; Ames FC; Singletary SE; Kuerer HM; Feig BW; Meric-Bernstam F; Hunt KK
Clin Nucl Med; 2005 Jan; 30(1):11-5. PubMed ID: 15604959
[TBL] [Abstract][Full Text] [Related]
8. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study.
Maza S; Valencia R; Geworski L; Sandrock D; Zander A; Audring H; Dräger E; Winter H; Sterry W; Munz DL
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):538-44. PubMed ID: 12582814
[TBL] [Abstract][Full Text] [Related]
9. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.
Kern KA; Rosenberg RJ
J Am Coll Surg; 2000 Nov; 191(5):479-89. PubMed ID: 11085727
[TBL] [Abstract][Full Text] [Related]
10. Lymphoscintigraphy and SPECT/CT in multicentric and multifocal breast cancer: does each tumour have a separate drainage pattern? Results of a Dutch multicentre study (MULTISENT).
Brouwer OR; Vermeeren L; van der Ploeg IM; Valdés Olmos RA; Loo CE; Pereira-Bouda LM; Smit F; Neijenhuis P; Vrouenraets BC; Sivro-Prndelj F; Jap-a-Joe SM; Borgstein PJ; Rutgers EJ; Oldenburg HS
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1137-43. PubMed ID: 22526968
[TBL] [Abstract][Full Text] [Related]
11. Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT.
Brouwer OR; Buckle T; Vermeeren L; Klop WM; Balm AJ; van der Poel HG; van Rhijn BW; Horenblas S; Nieweg OE; van Leeuwen FW; Valdés Olmos RA
J Nucl Med; 2012 Jul; 53(7):1034-40. PubMed ID: 22645297
[TBL] [Abstract][Full Text] [Related]
12. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients.
Heuts EM; van der Ent FW; von Meyenfeldt MF; Voogd AC
Eur J Surg Oncol; 2009 Mar; 35(3):252-7. PubMed ID: 18684584
[TBL] [Abstract][Full Text] [Related]
13. The impact of superficial injections of radiocolloids and dynamic lymphoscintigraphy on sentinel node identification in oral cavity cancer: a same-day protocol.
Tartaglione G; Vigili MG; Rahimi S; Celebrini A; Pagan M; Lauro L; Al-Nahhas A; Rubello D
Nucl Med Commun; 2008 Apr; 29(4):318-22. PubMed ID: 18317294
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
Gherghe M; Bordea C; Blidaru A
Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
[TBL] [Abstract][Full Text] [Related]
16. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
17. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.
Sanjuàn A; Vidal-Sicart S; Zanón G; Pahisa J; Velasco M; Fernández PL; Santamaría G; Farrús B; Muñoz M; Albanell J; Pons F; Vanrell JA
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):932-6. PubMed ID: 15791433
[TBL] [Abstract][Full Text] [Related]
18. [Intratumoral versus subareolar injection in breast cancer sentinel lymph node biopsy. A case report].
Lanchas Alfonso I; Miguel Martínez MB; CuezvaGuzmán JF; Rupérez Arribas P; Martínez Blanco S; Yartu San Millán JM; Duque Gallo JJ
Rev Esp Med Nucl; 2011; 30(3):171-3. PubMed ID: 21342723
[TBL] [Abstract][Full Text] [Related]
19. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
20. [Utility and advantages of single tracer subareolar injection in sentinel lymph node biopsy in breast cancer].
Armas F; Hernández MJ; Vega V; Gutiérrez I; Jiménez C; Pavcovich M; Báez B; Pérez-Correa P; Núñez V;
Cir Esp; 2005 Oct; 78(4):260-5. PubMed ID: 16420836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
